Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges episode artwork

EPISODE · Aug 19, 2024 · 18 MIN

Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges

from VJHemOnc Podcast · host VJHemOnc

This week's VJHemOnc podcast brings you updates in hemophilia from the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually. You hear from experts Omolade Awodu, MBChB, MD, FMCPath, University of Benin, Benin City, Nigeria, who discusses key hemophilia clinical trials in 2024, Radek Kaczmarek, PhD, Indiana University School of Medicine, Indianapolis, IN, who gives an overview of gene therapies for hemophilia, and Matteo Luciani, MD, Bambino Gesù Children’s Hospital, Rome, Italy, who shares insights into the remaining challenges for patients with hemophilia.

Episode metadata supplied by the publisher feed · Published Aug 19, 2024

Embed this episode

NOW PLAYING

Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges

0:00 18:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of VJHemOnc Podcast?

This episode is 18 minutes long.

When was this VJHemOnc Podcast episode published?

This episode was published on August 19, 2024.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this VJHemOnc Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!